Juno’s Scientific Advisors provide diversified expertise across our external advisory network.

José Baselga, M.D., Ph.D.

Chairman of Clinical Advisory Board

Bio

José Baselga is the Physician-in-Chief at Memorial Sloan-Kettering Cancer Center in New York City. His research interests are in clinical breast cancer and in translational and early clinical research. He conducted the initial clinical trials with the monoclonal antibodies cetuximab and trastuzumab and is leading the clinical development of several new agents including pertuzumab, everolimus, and PI3K inhibitors. His main focus in the laboratory and in the clinic is in the area of novel anti-HER2 agents, in the identification of mechanisms of resistance to anti-HER2 agents, and therapeutic approaches to target the PI3K pathway. He is also leading a number of neo-adjuvant trials in breast cancer and has been at the forefront of developing biomarker-based early and translational clinical trials. He led the two large phase III studies with pertuzumab in HER2 and everolimus in ER+ breast cancer that resulted in the approval of these two agents for the therapy of patients with breast cancer.
Dr. Baselga is past President of ESMO and a past member of the Board of Directors of AACR and ASCO. Dr. Baselga has received a number of awards including a Young Investigator Award and a Career Development Award from ASCO, Elected Member of the American Society of Clinical Investigation, AACR-Rosenthal Family Foundation Award, King James I Award, and the EACR Mike Price Gold Medal. He is the founding editor-in-chief on the new AACR flagship journal Cancer Discovery. Dr. Baselga has published over 300 peer-reviewed articles.
Dr. Baselga received his M.D. and Ph.D. degree from the Universidad Autonoma of Barcelona and completed a fellowship in Medical Oncology at Memorial Sloan-Kettering. Prior to his current position, he was the founding Director of the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Chief of the Division of Hematology/Oncology and Associate Director of the Massachusetts General Hospital Cancer Center in Boston and Professor of Medicine at Harvard Medical School.

Larry Corey, M.D.

Co-Founder & Sr. Scientific Advisor

Bio

Lawrence Corey is President and Director Emeritus of Fred Hutchinson Cancer Research Center and a member of its faculty in the Vaccine and Infectious Disease Division. He is also professor of medicine and laboratory medicine at the University of Washington and holder of the Lawrence Corey Endowed Chair in Medical Virology at the University of Washington.
Dr. Corey is an internationally renowned expert in virology, T cell immunology, and vaccine development. His research focuses on the immunology of herpes viruses, HIV, and infections related to cancer and he is known for his expertise in translational medicine, clinical trial design, and drug development. He is also Co-Principal Investigator of the HIV Vaccine Trials Network, an international collaboration of scientists and institutions dedicated to accelerating the development of HIV vaccine.
Dr. Corey is known for his leadership skills in developing collaborative networks of scientists to tackle difficult scientific problems. His honors and awards include election to the American Academy of Arts and Sciences and to the Institute of Medicine. Awards include the American Society for STD Research Parran Award, the University of Michigan Medical School Distinguished Alumnus Award, the Infectious Diseases Society of America Ender’s Award, and the Cubist Award from the American Society of Microbiology.
Dr. Corey received his medical degree from the University of Michigan. He has authored more than 670 scientific publications, 12 books, and more than 140 book chapters and editorials.

Jeff Bluestone, Ph.D.

Scientific Advisor

Bio

Jeffrey Bluestone was appointed Executive Vice Chancellor and Provost at the University of California, San Francisco (UCSF), in March 2010, having served in a number of posts including Director, UCSF Diabetes Center and the Immune Tolerance Network and as Interim Vice Chancellor.
As Executive Vice Chancellor and Provost, he serves as Chief Academic Officer, guides the research and academic enterprise at UCSF, advances the campus priorities in close collaboration with the chancellor and the campus leadership team, and oversees the campus ethics and compliance enterprise.
Through his 30-year scientific career, he has authored more than 300 peer-reviewed publications that include prominent papers in Nature, Nature Immunology, and the Journal of Immunology and Diabetes. He has received numerous accolades for his work, including his 2006 election to the American Academy of Arts and Sciences, the Mary Tyler Moore & Robert Levine Excellence in Clinical Research Award from the Juvenile Diabetes Research Foundation, and the Distinguished Alumni Award from the Cornell Graduate School of Medical Science.
Dr. Bluestone earned both his B.S. in Biology and his M.S. in Microbiology from Rutgers State University, and his Ph.D. in Immunology from the Cornell Graduate School of Medical Science (Sloan-Kettering Division).

Marc Tessier-Lavigne, Ph.D.

Scientific Advisor

Bio

Marc Tessier-Lavigne is President of Stanford University. A world leader in the study of brain development, he pioneered identification of molecules that direct the formation of neural circuits in the brain and spinal cord. He also studies nerve cell responses to injury and the mechanisms underlying nerve cell death in neurodegenerative disease. Dr. Tessier-Lavigne holds undergraduate degrees from McGill and Oxford universities and a Ph.D. from University College London. He performed postdoctoral work at the MRC Developmental Neurobiology Unit in London and at Columbia University and has served on the faculties of the University of California, San Francisco, and of Stanford University, where he was the Susan B. Ford Professor and a Howard Hughes Medical Institute investigator. In 2003, he joined Genentech, where he became Executive Vice President for Research and Chief Scientific Officer. From 2011- 2016, he was President of The Rockefeller University in New York City, where he was also Carson Family Professor and Head of the Laboratory of Brain Development and Repair. A Rhodes Scholar, Dr. Tessier-Lavigne is the recipient of numerous scientific awards and is an elected member of the U.S. National Academy of Sciences and its Institute of Medicine, and a fellow of the Royal Societies of the United Kingdom and Canada.